Organization · Type 2 NPI
New Jersey Institute for Disabilities, Inc
Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility · Manahawkin, NJ
Practice location
1022 Whispering Oak Ln
Manahawkin, NJ 08050-2629
Fax (732) 590-2431
Mailing address
10A Oak Drive Roosevelt Park
Edison, NJ 08837
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility Primary | 320900000X | None listed |
Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility: A home-like residential facility providing habilitation, support and monitoring services to individuals diagnosed with intellectual and/or developmental disabilities.
Other intellectual and/or developmental disabilities community based residential treatment facility providers in Manahawkin
- Community Options, IncIntellectual and/or Developmental Disabilities Community Based Residential Treatment Facility Manahawkin, NJ NPI 1154791648
- New Jersey Institute for Disabilities, IncIntellectual and/or Developmental Disabilities Community Based Residential Treatment Facility Manahawkin, NJ NPI 1205650587
- New Jersey Institute for Disabilities, IncIntellectual and/or Developmental Disabilities Community Based Residential Treatment Facility Manahawkin, NJ NPI 1255812293
- Community Options, Inc.Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility Manahawkin, NJ NPI 1487218566
- Community Options, IncIntellectual and/or Developmental Disabilities Community Based Residential Treatment Facility Manahawkin, NJ NPI 1609245091
About NPI 1043084171
New Jersey Institute for Disabilities, Inc's National Provider Identifier is 1043084171, issued on Nov 9, 2023. The primary taxonomy on file is Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility (320900000X), and the practice location is in Manahawkin, NJ. The record was last updated on Feb 20, 2024.